PolyPeptide Group AG (XSWX:PPGN)
CHF 32.45 -0.2 (-0.61%) Market Cap: 1.07 Bil Enterprise Value: 1.09 Bil PE Ratio: 0 PB Ratio: 2.94 GF Score: 86/100

Half Year 2023 PolyPeptide Group AG Corporate Sales Call Transcript

Jul 13, 2023 / 07:30AM GMT
Release Date Price: CHF17.44 (-5.06%)
Operator

Ladies and gentlemen, welcome to the PolyPeptide Group Audio Webcast and Conference Call. I am Alice, the Chorus Call operator.

(Operator Instructions)

And the conference is being recorded.

(Operator Instructions)

The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Michael Staheli, Head of Investor Relations and Corporate Communications at PolyPeptide Group. Please go ahead, sir.

Michael Staheli
PolyPeptide Group AG - Head of IR & Corporate Communications

Yes. Good morning, everybody. Thank you for joining our call on such short notice. We appreciate your interest in PolyPeptide. I'm joined by Juan-Jose Gonzalez, our new CEO; and Lalit Ahluwalia, our interim CFO. Lalit supports us with his deep experience in pharmaceutics and generics, in finance, until our new permanent CFO, is in place.

Juan Jose will give you a short overview, and then both are available to answer your questions. We planned this call to run for around 30 to 40 minutes, so please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot